Sun Pharmaceutical Fair Value
SU
The fair market value of SUNPHARMA.NS stock is 1462.93 INR. Relative to the market price of 1836 INR Sun Pharmaceutical Industries is overvalued by 20.3%
Eyestock's quantitative valuation approach is based on the method of estimating historical multipliers. To determine whether a stock is undervalued, we compare its current price to our estimated of fair value. The more undervalued a stock is, the more investment is profitable.
Fair Relative Value
Sun Pharmaceutical Valuation
Current SUNPHARMA.NS share ticker price is 1836 INR.
The fair value level of 1462.93 INR can be considered as an effective entry point for long-term investors to start investing in SUNPHARMA.NS stock. For a more in-depth assessment, we provide a minimum value that can be used to increase a stock position and a maximum one that can be used to reduce it.
Price chart is not available
Current market price
Current price is 20% higher its fair value
Current price is 51% higher its minimum value
Current price is 46% lower its maximum value
Market price:
SUNPHARMA.NS stock is overvalued
It means the current price may concern as a Risky Entry Point
Sun Pharmaceutical Industries Ltd Stock Valuation Calculator
How do we value a stock?
As fair value, we use the product of the median Price-to-earnings ratios at the end of each reporting period for the last 5 years and earnings per share for the last 12 months. By analogy with the fair value, we calculate the maximum and minimum ones using the corresponding P/E extremums.
1
Maximum P/E over 5 years
67.06
2
Median P/E over 5 years
36.58
3
Minimum P/E over 5 years
22.45
4
Earning per share (last 12 months)
40 INR
Maximum value
1
x
4
=
2 682.37 INR
Fair value
2
x
4
=
1 462.93 INR
Minimum value
3
x
4
=
898.02 INR
Sun Pharmaceutical Industries Ltd price metrics
34.2
Annual return (geometric mean)
25.4
Risk (standard deviation) of returns
β
0.5
Beta (volatility compared to market)